NCT03421275 is a Phase 4 clinical trial of Esketamine in Acute Pain Due to Trauma, sponsored by Anna Meuronen, MD.

Who is sponsoring NCT03421275?

NCT03421275 is sponsored by Anna Meuronen, MD.

What drugs are being tested in NCT03421275?

Interventions in NCT03421275: Esketamine, Fentanyl Citrate, Saline Nasal.

What condition does NCT03421275 study?

NCT03421275 studies Acute Pain Due to Trauma.

Is NCT03421275 still recruiting?

NCT03421275 is currently status unknown. Last updated 13 February 2020.

Last reviewed 2020-02-13 · How we verify

NCT03421275

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intranasal Esketamine and Fentanyl for Pain in Minor Trauma

Status unknown Phase 4 Last updated 13 February 2020

What this trial tests

Phase 4 trial testing Esketamine in Acute Pain Due to Trauma in 105 participants. Status unknown.

Timeline

1 December 2017

Primary endpoint
1 December 2022

1 December 2022

Quick facts

Lead sponsor	Anna Meuronen, MD
Phase	Phase 4
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	105
Start date	1 December 2017
Primary completion	1 December 2022
Estimated completion	1 December 2022
Sites	1 location across Finland

Drugs / interventions tested

Esketamine (ESKETAMINE) — full drug profile →
Fentanyl Citrate — full drug profile →
Saline Nasal

Conditions studied

Acute Pain Due to Trauma — all drugs for Acute Pain Due to Trauma →

Sponsor

Anna Meuronen, MD

Who can join

Adults 18 to 80, any sex, with Acute Pain Due to Trauma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Intranasal esketamine, fentanyl and placebo are compared in treatment of acute pain in adult patients with minor trauma. Study is blinded randomized placebo-controlled parallel design.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Esketamine

Trials testing the same drug.

NCT07315074 — Effect of Esketamine on Postoperative Sleep in Postmenopausal Women · NA · not yet recruiting
NCT07374458 — Effects of Esketamine and Bilateral Lower Limb Elevation on Hemodynamic Stability During Induction of General Anesthesia · NA · not yet recruiting
NCT07227454 — A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder · Phase 3 · recruiting
NCT06788444 — Efficacy of Esketamine for Patients With Irritable Bowel Syndrome · NA · recruiting
NCT07179913 — The Improvement of Low-dose Esketamine on Postoperative Depression in Patients Undergoing Bariatric Surgery With Preoper · Phase 4 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03421275 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Anna Meuronen, MD
Last refreshed: 13 February 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03421275.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing